It has been proposed that the anti-viral and anti-tumor effects of imiquimod in the skin are mediated by activation of TLR7 and/or TLR8 expressed by monocytes, macrophages, and plasmacytoid dendritic cells (pDCs). This evidence concerns the gene TLR8 and neoplasm.